Literature DB >> 28781163

Polypharmacology of conformationally locked methanocarba nucleosides.

Kenneth A Jacobson1, Dilip K Tosh2, Kiran S Toti2, Antonella Ciancetta2.   

Abstract

A single molecular scaffold can be adapted to interact with diverse targets, either separately or simultaneously. Nucleosides and nucleotides in which ribose is substituted with bicyclo[3.1.0]hexane are an example of a versatile drug-like scaffold for increasing selectivity at their classical targets: kinases, polymerases, adenosine and P2 receptors. Also, by applying structure-based functional group manipulations, rigidified adenosine derivatives can be repurposed to satisfy pharmacophoric requirements of various GPCRs, ion channels, enzymes and transporters, initially detected as off-target activities. Recent examples include 5HT2B serotonin receptor antagonists and novel dopamine transporter allosteric modulators. This directable target diversity establishes rigid nucleosides as privileged scaffolds. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28781163      PMCID: PMC5705437          DOI: 10.1016/j.drudis.2017.07.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  67 in total

1.  Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.

Authors:  Hiroshi Maruoka; Matthew O Barrett; Hyojin Ko; Dilip K Tosh; Artem Melman; Lauren E Burianek; Ramachandran Balasubramanian; Barkin Berk; Stefano Costanzi; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

2.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

3.  Influence of sugar ring conformation on the transportability of nucleosides by human nucleoside transporters.

Authors:  Vijaya L Damaraju; Delores Mowles; Kyla M Smith; Sylvia Y M Yao; James D Young; Victor E Marquez; Carol E Cass
Journal:  Chembiochem       Date:  2011-11-04       Impact factor: 3.164

4.  Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.

Authors:  Kevin Trujillo; Silvia Paoletta; Evgeny Kiselev; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2015-03-21       Impact factor: 3.641

Review 5.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

Review 6.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

7.  Identification of Highly Promising Antioxidants/Neuroprotectants Based on Nucleoside 5'-Phosphorothioate Scaffold. Synthesis, Activity, and Mechanisms of Action.

Authors:  Sagit Azran; Ortal Danino; Daniel Förster; Sarah Kenigsberg; Georg Reiser; Mudit Dixit; Vijay Singh; Dan T Major; Bilha Fischer
Journal:  J Med Chem       Date:  2015-10-16       Impact factor: 7.446

8.  Synthesis of ethyl (1S,2R,3S,4S,5S)-2,3-O-(isopropylidene)-4-hydroxy-bicyclo[3.1.0]hexane-carboxylate from L-ribose: a versatile chiral synthon for preparation of adenosine and P2 receptor ligands.

Authors:  Bhalchandra V Joshi; Artem Melman; Richard L Mackman; Kenneth A Jacobson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-03       Impact factor: 1.381

9.  Structural probing of off-target G protein-coupled receptor activities within a series of adenosine/adenine congeners.

Authors:  Silvia Paoletta; Dilip K Tosh; Daniela Salvemini; Kenneth A Jacobson
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

10.  Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective.

Authors:  Alan Talevi
Journal:  Front Pharmacol       Date:  2015-09-22       Impact factor: 5.810

View more
  10 in total

1.  Survey of ribose ring pucker of signaling nucleosides and nucleotides.

Authors:  Veronica Salmaso; Kenneth A Jacobson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2019-08-28       Impact factor: 1.381

2.  A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity.

Authors:  Dilip K Tosh; Veronica Salmaso; Ryan G Campbell; Harsha Rao; Amelia Bitant; Eline Pottie; Christophe P Stove; Naili Liu; Oksana Gavrilova; Zhan-Guo Gao; John A Auchampach; Kenneth A Jacobson
Journal:  Eur J Med Chem       Date:  2021-11-19       Impact factor: 6.514

Review 3.  Expanding the repertoire of methanocarba nucleosides from purinergic signaling to diverse targets.

Authors:  Kenneth A Jacobson; Veronica Salmaso; R Rama Suresh; Dilip K Tosh
Journal:  RSC Med Chem       Date:  2021-07-13

4.  Integrated Whole-Transcriptome Profiling and Bioinformatics Analysis of the Polypharmacological Effects of Ganoderic Acid Me in Colorectal Cancer Treatment.

Authors:  Nianhong Chen; Guoqing Wan; Xiaobin Zeng
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

5.  Exploration of Alternative Scaffolds for P2Y14 Receptor Antagonists Containing a Biaryl Core.

Authors:  Young-Hwan Jung; Jinha Yu; Zhiwei Wen; Veronica Salmaso; Tadeusz P Karcz; Ngan B Phung; Zhoumou Chen; Sierra Duca; John M Bennett; Steven Dudas; Daniela Salvemini; Zhan-Guo Gao; Donald N Cook; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2020-08-06       Impact factor: 7.446

6.  Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists.

Authors:  Dilip K Tosh; Antonella Ciancetta; Philip Mannes; Eugene Warnick; Aaron Janowsky; Amy J Eshleman; Elizabeth Gizewski; Tarsis F Brust; Laura M Bohn; John A Auchampach; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  ACS Omega       Date:  2018-10-04

7.  Structure activity relationship of novel antiviral nucleosides against Enterovirus A71.

Authors:  Dilip K Tosh; Kiran S Toti; Brett L Hurst; Justin G Julander; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2020-10-05       Impact factor: 2.823

8.  Convergent synthesis of 2-thioether-substituted (N)-methanocarba-adenosines as purine receptor agonists.

Authors:  R Rama Suresh; Russell B Poe; Baorui Lin; Kexin Lv; Ryan G Campbell; Zhan-Guo Gao; Theodore E Liston; Kiran S Toti; Kenneth A Jacobson
Journal:  RSC Adv       Date:  2021-08-11       Impact factor: 4.036

9.  Stereoselective synthesis and application of isopulegol-based bi- and trifunctional chiral compounds.

Authors:  Tam Minh Le; Thu Huynh; Gábor Endre; András Szekeres; Ferenc Fülöp; Zsolt Szakonyi
Journal:  RSC Adv       Date:  2020-10-19       Impact factor: 4.036

10.  Stereoselective Synthesis and Antiproliferative Activity of Steviol-Based Diterpen Aminodiols.

Authors:  Dániel Ozsvár; Viktória Nagy; István Zupkó; Zsolt Szakonyi
Journal:  Int J Mol Sci       Date:  2019-12-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.